Marksans Pharma has informed that a meeting of the Board of Directors of the company will be held on May 29, 2014 to consider and approve Annual Audited Financial Results of the company for the financial year ended March 31, 2014 and to consider recommendation of dividend, if any, for the financial year ended March 31, 2014.
The above information is a part of company’s filings submitted to BSE.